MARSHALL WACE, LLP - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 79 filers reported holding CARDLYTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$17,338,883
+143.8%
1,050,841
-6.6%
0.04%
+150.0%
Q2 2023$7,112,472
+111.7%
1,125,391
+13.9%
0.01%
+100.0%
Q1 2023$3,360,329
+165.4%
988,332
+351.2%
0.01%
+133.3%
Q4 2022$1,266,080
-36.4%
219,045
+3.5%
0.00%
-25.0%
Q3 2022$1,990,000
-51.4%
211,696
+15.2%
0.00%
-50.0%
Q2 2022$4,097,000
+199.9%
183,728
+789.2%
0.01%
+166.7%
Q4 2021$1,366,000
-91.4%
20,662
-83.6%
0.00%
-95.8%
Q2 2021$15,946,000
+77.9%
125,630
+53.8%
0.07%
+75.6%
Q1 2021$8,961,000
+176.3%
81,680
+259.6%
0.04%
+127.8%
Q4 2020$3,243,000
+382.6%
22,717
-44.1%
0.02%
+500.0%
Q1 2019$672,00040,6580.00%
Other shareholders
CARDLYTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Versant Capital Management, Inc 43$3960.00%
View complete list of CARDLYTICS INC shareholders